Neonc Technologies Inc.

NTHI | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.33

+$0.07 (+2.15%)

At close: Sep 21, 2026, 4:00 PM ET

$3.40

+$0.07 (+2.10%)

Pre-market: Sep 22, 2026, 5:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.15%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $86.35M

1D Range

3.28 3.48

52W Range

2.96 12.99

Valuation (TTM)

PE -1.50

PB -4.66

EV/EBITDA -1.94

Valuation (NTM)

Forward PE N/A

Forward PEG 0.08

Price Target $16

Cash Flow

FCF Yield -24.5%

SBC Adj. FCF Yield -44.6%

SBC Impact -82.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -902.2%

ROE 309.1%

ROIC 229.4%

Financial Health

Net Cash

$1.9M

Current Ratio 0.14

Interest Coverage -12.41

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central ne...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Mar 25, 2025

Website www.neonctech.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$15

Upside

+350.45%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞